$1.3tr
$XX.Xbn
116k
2,762
$XX.Xbn
The Pharmaceuticals Wholesaling industry has grown as changing demographics, along with a rising number of physician visits, have propelled demand. The aging of the US population has also boosted revenue growth, as individuals generally require and purchase more medications as they get older. As a result, revenue is expected to increase at a CAGR of 5.4% to $1.3 trillion over the five years to 2023. However, intense external competition from e-commerce pharmaceutical retailers has pressured the industry, which is expected to fuel increased consolidation as wholesalers attempt to bolster profit margins by establishing economies of scale.
Industry revenue has grown at a CAGR of 5.4 % over the past five years, to reach an estimated $1.3tr in 2023.
Market size is projected to grow over the next five years.
Company | Market Share (%)
2023 | Revenue ($m)
2023 | Profit ($m)
2023 | Profit Margin (%)
2023 |
---|---|---|---|---|
Mckesson Corporation | 189,506.6 | 1,816.0 | 1.0 | |
Amerisourcebergen Corp | 186,429.0 | 1,128.9 | 0.6 | |
Cardinal Health, Inc. | 132,768.5 | 2,048.9 | 1.5 |
To view the market share and analysis for all 3 top companies in this industry, view purchase options.
Industry revenue is measured across several distinct product and services lines, including Prescription drugs, Nonprescription drugs and Vitamins and nutritional supplements. Prescription drugs is the largest segment of the Pharmaceuticals Wholesaling in the US.
Prescription drugs are costly
This industry distributes medicines intended to diagnose, treat and prevent diseases. The industry includes operators that take ownership of goods to be distributed, and does not include manufacturers that sell medicines, equipment and supplies directly to hospitals or doctors’ offices.
Purchase this report to view all 3 major companies in this industry.
NAICS 42421 - Pharmaceuticals Wholesaling in the US
Get an indication of the industry's health through historical, current and forward-looking trends in the performance indicators that make or break businesses.
Changing demographics have propelled demand for pharmaceuticals. As Americans are living longer, their dependence on over-the-counter (OTC) and prescription drugs is rising.
Learn about an industry's products and services, markets and trends in international trade.
Brand-name drugs generate the bulk of revenue. Without generic equivalents, brand-name products can charge higher prices.
Discover where business activity is most concentrated in an industry and the factors driving these trends to find opportunities and conduct regional benchmarking.
The West region is a major location for industry wholesalers. Its importance is underscored by its large share of the domestic population.
Get data and insights on what's driving competition in an industry and the challenges industry operators and new entrants may face, with analysis built around Porter's Five Forces framework.
Pharmaceutical wholesaling is highly competitive. The largest companies compete with each other on a wide range of product mix, price, sales service and distribution networks...
Learn about the performance of the top companies in the industry.
The Big Three dominate the industry. McKesson, AmerisourceBergen and Cardinal Healthcare account for more than 60.0% of revenue.
Understand the demographic, economic and regulatory factors that shape how businesses in an industry perform.
Pharmaceutical wholesaling is highly regulated at both the federal and state level. Regulation covers the supply chain that wholesalers are involved in and areas, such as hea...
View average costs for industry operators and compare financial data against an industry's financial benchmarks over time.
Wholesalers have experienced competitive pressure from e-commerce retailers, slimming margins. This has encouraged consolidation among the largest companies.
Including values and annual change:
IBISWorld has been a leading provider of trusted industry research for over 50 years to the most successful companies worldwide. With offices in Australia, the United States, the United Kingdom, Germany and China, we are proud to have local teams of analysts that conduct research, data analysis and forecasting to produce data-driven industry reports.
Our analysts start with official, verified and publicly available sources of data to build the most accurate picture of each industry. Analysts then leverage their expertise and knowledge of the local markets to synthesize trends into digestible content for IBISWorld readers. Finally, each report is reviewed by one of IBISWorld’s editors, who provide quality assurance to ensure accuracy and readability.
IBISWorld relies on human-verified data and human-written analysis to compile each standard industry report. We do not use generative AI tools to write insights, although members can choose to leverage AI-based tools within the platform to generate additional analysis formats.
Each industry report incorporates data and research from government databases, industry-specific sources, industry contacts, and our own proprietary database of statistics and analysis to provide balanced, independent and accurate insights.
Key data sources in the US include:
Analysts also use industry specific sources to complement catch-all sources, although their perspective may focus on a particular organization or representative body, rather than a clear overview of all industry operations. However, when balanced against other perspectives, industry-specific sources provide insights into industry trends.
These sources include:
Finally, IBISWorld’s global data scientists maintain a proprietary database of macroeconomic and demand drivers, which our analysts use to help inform industry data and trends. They also maintain a database of statistics and analysis on thousands of industries, which has been built over our more than 50-year history and offers comprehensive insights into long-term trends.
IBISWorld’s analysts and data scientists use the sources above to create forecasts for our proprietary datasets and industry statistics. Depending on the dataset, they may use regression analysis, multivariate analysis, time-series analysis or exponential smoothing techniques to project future data for the industry or driver. Additionally, analysts will leverage their local knowledge of industry operating and regulatory conditions to impart their best judgment on the forecast model.
IBISWorld prides itself on being a trusted, independent source of data, with over 50 years of experience building and maintaining rich datasets and forecasting tools. We are proud to be the keystone source of industry information for thousands of companies across the world.
Learn more about our methodology and data sourcing on the Help Center.
Unlock comprehensive answers and precise data upon purchase. View purchase options.
The market size of the Pharmaceuticals Wholesaling in the US industry in United States is $1.3tr in 2024.
There are 2,762 businesses in the Pharmaceuticals Wholesaling in the US industry in United States, which has declined at a CAGR of 1.2 % between 2018 and 2023.
The market size of the Pharmaceuticals Wholesaling in the US industry in United States has been growing at a CAGR of 5.4 % between 2018 and 2023.
Over the next five years, the Pharmaceuticals Wholesaling in the US industry in United States is expected to grow.
The biggest companies operating in the Pharmaceuticals Wholesaling market in United States are Mckesson Corporation, Amerisourcebergen Corp and Cardinal Health, Inc.
Antibiotics wholesaling and Prescription drugs wholesaling are part of the Pharmaceuticals Wholesaling in the US industry.
The company holding the most market share in United States is Mckesson Corporation.
The level of competition is high and increasing in the Pharmaceuticals Wholesaling in the US industry in United States.